Group Discussion Deepens Over WHO Role In Stopping Poor Quality Medicines 01/03/2011 by Catherine Saez, Intellectual Property Watch Leave a Comment The role of the World Health Organization in the safety, quality and efficacy of medical products is under scrutiny this week by member states and stakeholders. In particular, the focus is on the WHO’s role in the prevention and control of medical products of compromised quality, the organisation’s relationship with the international taskforce against counterfeit products, and the taskforce’s alleged focus on the protection of intellectual property rights rather than on public health issues. In several documents, the WHO tries to explain this fragile role.
WHO Members To Work To Disentangle Problem Of Fake Medicines, IP Issues 26/02/2011 by Catherine Saez, Intellectual Property Watch Leave a Comment A designated working group will meet for the first time this week to discuss the World Health Organization’s role in the safety, quality and efficacy of medical products, but some countries are concerned about what they consider to be the unwelcome intrusion of intellectual property rights issues into the debate.
Building A Consensus To Address The Health Threat Posed By Fake Medicines 25/02/2011 by Intellectual Property Watch 1 Comment On the eve of a meeting of the WHO working group on substandard/spurious/falsely-labelled/falsified/counterfeit medical products, research-based pharmaceutical industry group IFPMA sets out thoughts on building global consensus to address fake medicines.
WHO, WTO, WIPO Combine Forces To Improve Patent Information For Public Health 18/02/2011 by Catherine Saez, Intellectual Property Watch 1 Comment Patents and public health are sometimes seen as a mismatch, but three prominent international organisations today stepped up their collaboration on ways to facilitate access to medicines by making a better use of the patent system. Effective, reliable and transparent information on patents is necessary to help decision-makers take the best public health approaches for global health coverage, panellists said.
WHO Gears Up For Reform Driven By Financial Shortfall 25/01/2011 by Catherine Saez, Intellectual Property Watch 4 Comments The Executive Board session of the World Health Organization ended early on Monday after a week of discussions that settled some issues but left some others for the next governing meeting of the organisation in May, with much to do until then. The WHO is facing a significant gap in its budget and a programme of reforms is brewing.
WHO R&D Financing Committee Approved With Controversial Industry Expert 22/01/2011 by Catherine Saez, Intellectual Property Watch 4 Comments World Health Organization members yesterday struck a compromise allowing a Swiss industry representative to sit on a committee selecting proposals for research and developing financing for neglected diseases, disregarding the fact that he is author of one of the proposals. Special safeguards were added to prevent undue influence, but questions remain for some about a conflict of interest.
WHO Members Show Dismay At Delay On Counterfeit Medicines Group 19/01/2011 by Catherine Saez, Intellectual Property Watch 4 Comments World Health Organization members today raised strong concerns that a working group they mandated last May to address problems with WHO policy on counterfeit and substandard medicines has yet to be formed – with four months remaining before it must report back to members. One delegation called for a halt to WHO activities on anti-counterfeiting until the outcome of the working group is accepted by member states.
New Rules Eyed For Election Of WHO Director General 18/01/2011 by Catherine Saez, Intellectual Property Watch 2 Comments With the World Health Organization director general’s term of office ending next year, WHO members today set up a drafting group to try to reconcile divergent views on the process leading to the election. Some countries are in favour of a principle of geographical rotation – citing over 60 years of no representation from their regions, while some other countries claimed rotation could override more important selection criteria such as expertise and experience, and could endanger the organisation’s future.
WHO Future In Question; Debate Over Industry Representation 17/01/2011 by Catherine Saez and William New, Intellectual Property Watch 3 Comments A seemingly overworked and impoverished World Health Organization opened its Executive Board session today with calls for reform amid deep concerns about its financial future. Meanwhile, dissension arose over an industry representative named by the WHO secretariat to a new research and development funding working group, sparking the WHO director general to cast doubt on the role of industry in such groups.
Roche Exec Takes Over At Medicines For Malaria Venture 06/01/2011 by William New, Intellectual Property Watch 1 Comment A top Swiss company executive on pandemic influenza and HIV/AIDS research took the reins of the Geneva-based Medicines for Malaria Venture this week, just weeks after MMV was given international organisation status by the Swiss government.